$2.99-0.51 (-14.57%)
Hyperion DeFi, Inc.
Hyperion DeFi, Inc. in the Healthcare sector is trading at $2.99. Wall Street consensus targets $6.12 (2 analysts), implying a +104.8% move over the next 12 months. The stock is currently near its 52-week low of $2.11, remaining 40.3% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Hyperion DeFi, Inc. operates as a digital asset treasury and ophthalmic technology company in the United States. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HY...
Hyperion DeFi Inc (HYPD) raises full-year guidance by 20% despite challenges, showcasing robust DeFi strategy execution.
Hyunsu Jung: Thank you, Jason, and good morning, everyone. In our first earnings call at Hyperion DeFi, we made a promise, stating that we would set ourselves apart from other digital asset treasury companies with our comprehensive ecosystem engagement strategy. At the time, it may have been difficult for investors to understand the concept of DeFi, let alone the idea of a public company using these strategies to generate revenue.
Hyperion DeFi Inc (HYPD) reports an impressive 87% revenue growth and strategic advancements, despite facing significant treasury losses in Q4 2025.
As bitcoin, ethereum and other cryptocurrencies see major legal, institutional, and technological developments, the financial landscape continues to adapt. Stay up on the crypto news that matters with the “Crypto Currents” weekly from The Fly. Also, join us for your essential daily recap, every day at 2 PM ET on FlyCast radio.Claim 30% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and ana
Public companies are not just assessing crypto potential; they are buying in. Since the approval of spot ETFs in 2024 and throughout 2025, multiple firms in the US have been actively purchasing and adding top cryptos to their balance sheets. Strategy, formerly MicroStrategy, is well known for its Bitcoin holding ...